What's new

Human medicines European public assessment report (EPAR): Orphacol, cholic acid, Date of authorisation: 12/09/2013, Date of refusal: 25/05/2012, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR): Orphacol, cholic acid, Date of authorisation: 12/09/2013, Date of refusal: 25/05/2012, Revision: 15, Status: Authorised

Apr 11, 2025 - 10:09
 0
Human medicines European public assessment report (EPAR): Orphacol, cholic acid, Date of authorisation: 12/09/2013, Date of refusal: 25/05/2012, Revision: 15, Status: Authorised
Human medicines European public assessment report (EPAR): Orphacol, cholic acid, Date of authorisation: 12/09/2013, Date of refusal: 25/05/2012, Revision: 15, Status: Authorised
Read More

Tags:

Previous Article

Drury Hotels Opens New 252-Room Hotel in Charleston, South Carolina

Next Article

Emergency Task Force (ETF)

Related Posts

Human medicines European public assessment report (EPAR): Strimvelis, autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence, Date of authorisation: 26/05/2016, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 27, 2025  0

Human medicines European public assessment report (EPAR): Yondelis, trabectedin, Date of authorisation: 17/09/2007, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 3, 2025  0

Human medicines European public assessment report (EPAR): Torisel, temsirolimus, Date of authorisation: 19/11/2007, Revision: 35, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025  0